Prostate Cancer Clinical Consortium Clinical Research Site:Targeted Therapies

Abstract

The Weill Cornell Medical College Prostate Cancer Research Program (WCMC-PCRP) is a Clinical Research Site of the Prostate Cancer Clinical Trials Consortium (PCCTC). The purpose of the research is to lead and participle in Consortium therapeutic and correlative science research protocols. Specifically, our aims are to impact prostate cancer care and outcomes through the development and study of novel targeted therapeutics, discovery of mechanisms of therapy resistance/sensitivity, identification of new therapeutic targets through high quality genomic analyses, providing access to the highest quality PC tissue specimens, and development of molecular imaging techniques with direct relevance to targeted therapies. Our overarching goal is to more effectively bring novel agents and new biomarker driven trials directly to patients

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Oct 01, 2015
Accession Number
AD1005307

Entities

People

  • David Nanus

Organizations

  • Weill Cornell Medicine

Tags

DTIC Thesaurus Topics

  • Androgen Receptors
  • Biomedical Research
  • Clinical Trials
  • Consortiums
  • Data Analysis
  • Diseases And Disorders
  • Electronic Mail
  • Health Services
  • Information Science
  • Institutional Review Board
  • Medical Personnel
  • Neoplasms
  • Oncology
  • Prostate
  • Prostate Cancer
  • Quality Of Life
  • Therapy

Fields of Study

  • Medicine

Readers

  • Oncology
  • Research Science/Academic Research